Anaphylatoxins inhibit C2 production.

Area of Science:

• Immunology
• Complement System Biology

Background:

• Anaphylatoxins (C5a, C3a) are key mediators in inflammatory and immune responses.
• Complement factor C2 is crucial for both classical and lectin complement pathways.

Purpose of the Study:

• To investigate the effect of anaphylatoxins and their des-Arg derivatives on complement factor C2 production.
• To elucidate the intracellular mechanisms, specifically cyclic AMP (cAMP) involvement, underlying this inhibition.

Main Methods:

• Mononuclear phagocytes were cultured and treated with varying concentrations of C5a, C3a, C5adesArg, and C3adesArg.
• Complement factor C2 levels in culture supernatants were quantified.
• Intracellular cAMP levels were measured.
• The impact of indomethacin and ETYA on C2 production was assessed.

Main Results:

• Anaphylatoxins C5a and C3a, along with their des-Arg derivatives, significantly inhibited C2 production.
• C5a and C5adesArg were more potent inhibitors than C3a and C3adesArg.
• Inhibition of C2 production was minimally affected by indomethacin or ETYA.
• Anaphylatoxin treatment led to increased intracellular cAMP levels, which inversely correlated with C2 production.

Conclusions:

• Anaphylatoxins potently inhibit C2 production by mononuclear phagocytes.
• The inhibitory effect of anaphylatoxins on C2 production is likely mediated by an increase in intracellular cAMP levels.
• This suggests a cAMP-dependent mechanism regulating complement factor C2 synthesis in response to anaphylatoxins.